The Genomics of Common Diseases

The Wellcome Trust in association with Nature Genetics is pleased to
announce the 9th annual Genomics of Common Diseases.

Genome-wide association studies and the emergence of new sequencing
technologies has helped refine our understanding of the genetic
architecture of disease. This past year has seen a continuing increase in
the scale of genomic data sets and important strides in identifying
functionally and clinically relevant genetic variation.

This year’s conference will feature leading examples of genetic discovery
efforts for common diseases using a range of technologies, including
genotyping arrays, as well as targeted-, exome- and whole-genome
sequencing. We will also focus on approaches to characterize regulatory
variation, how to use model organisms as a way to move from association
to function and increase the mechanistic understanding of disease. The
meeting will highlight important recent efforts in clinical translation
and survey a range of global genomic medicine programmes.

The meeting will address the following topics, across a range of common
diseases:

• Autoimmunity
• Cancer genomics
• Clinical translation
• Evolutionary and population genomics
• Genetic discovery
• Genome technology
• Genome medicine
• Genomic architecture
• Mechanisms of disease
• Model organisms
• Neuropsychiatric disorders
• Regulatory variation

The conference will start at approximately 13.00 on Wednesday, 2
September and close at approximately 14.00 on Saturday, 5 September 2015.

Scientific sessions

• Integrative genomics
• Genetic discovery
• Regulatory variation
• Clinical genetics & translation
• Cancer genomics
• Genome technology
• Genome medicine
• Population genomics

Scientific programme committee
Myles Axton Nature Genetics, USA
Orli Bahcall Nature Genetics, USA
Wendy Bickmore University of Edinburgh, UK
Peter Campbell Wellcome Trust Sanger Institute, UK
Aravinda Chakravarti Johns Hopkins University School of Medicine, USA
Michael Dunn Wellcome Trust, UK
Sekar Kathiresan Massachusetts General Hospital, USA
Teri Manolio National Human Genome Research Institute, National Institutes of Health, USA
Mark McCarthy University of Oxford, UK

Keynote speakers
George Church Harvard Medical School, USA
Anne Ferguson-Smith University of Cambridge, UK
Vanessa Hayes Garvan Institute of Medical Research, Australia

Confirmed speakers
Rene Bernards Netherlands Cancer Institute, The
Netherlands
Erwin Bottinger Mount Sinai Hospital, USA
Han Brunner Radboud University Nijmegen Medical Center, The
Netherlands
Wasun Chantratita Mahidol University, Thailand
Rory Collins University of Oxford, UK
Manolis Dermitzakis University of Geneva Medical School,
Switzerland
Peter Donnelly University of Oxford, UK
Evan Eichler University of Washington, USA
David Fitzpatrick University of Edinburgh, UK
Mathew Garnett Wellcome Trust Sanger Institute, UK
Doug Higgs University of Oxford, UK
Gail Jarvik University of Washington, USA
Jan Korbel EMBL, Germany
Yuk Ming Dennis Lo The Chinese University of Hong Kong, Hong
Kong
Steven McCarroll Harvard Medical School, USA
Miles Parkes University of Cambridge, UK
Heidi Rehm Partners HealthCare and Harvard Medical School,
USA
Gad Rennert Israel Institute of Technology, Israel
John Rioux Université de Montréal, Canada
Nitzan Rosenfeld University of Cambridge, UK
Albin Sandelin University of Copenhagen, Denmark
Nicole Soranzo Wellcome Trust Sanger Institute, UK
Charles Swanton The Francis Crick Institute, UK
Sarah Teichmann EMBL-EBI, UK
John Todd University of Cambridge, UK

Conference organiser
Laura Hubbard Wellcome Genome Campus, UK

Registration Fees:

The registration fee includes entrance to the lectures and poster
sessions, an abstract book, meals (lunch and dinner) and refreshments
during the conference. Breakfast will be provided for delegates who have
booked accommodation.

Registration deadline: Closed

Accommodation
Accommodation is provided for the nights of 2, 3, 4 September 2015.
Please note there is limited on-site accommodation and this will be
allocated on a first-come first-served basis. Therefore, early
registration is recommended.
If you wish to book onsite accommodation either side of the conference
dates, please contact the Conference Centre directly.

Travel visas
Please contact the conference organiser if you require a letter to
support a travel visa application. Note that letters will be provided to
confirmed registrants.

A limited number of registration bursaries are available for PhD students
to attend this conference (up to 50% of the registration fee) from
Wellcome Genome Campus Scientific Conferences.

Bursary deadline: Closed

We welcome abstracts from all areas relevant to the main themes of the
meeting for both oral and poster presentations. Several oral
presentations will be chosen from the abstracts submitted.

Please register prior to submitting your abstract. Abstracts will not be
considered from anyone who has not registered to attend the conference.
Please follow the guidelines below when submitting your abstract.

Please specify which session(s) you would like your
abstract to be
considered for by saving the document with the
presenter’s last name
followed by the session name.

The scientific programme committee will assess your abstract after
deadline has passed and you will be notified whether you have been
selected for an oral or poster presentation.

Poster boards onsite will accommodate 118 cm high by 84 cm wide (A0-
portrait) of printed material. Accepted abstracts will appear in the
conference programme book and poster boards will be allocated at the
conference.

Abstract deadline: Closed

Abstract guidelines

• Format & Font: Prepare your abstract in Microsoft Word in 11-point Ariel Font.
• Title: The title should be concise and be in bold, sentence case.
• Author names: The presenting author’s name must be the first name to appear on the list of authors. Underline the name of the presenting author. For each author give the forename followed by the surname.
• Affiliations: Please list the authors and affiliations directly under the title, separated by one empty line, and followed on additional lines as necessary. Indicate each author’s affiliation with a superscript numeral following the surname.
• Abstract length: should not exceed one 1.5-spaced page. The total word limit is 400 words (to include title, authors, affiliations and abstract narrative).
• Abstract narrative: must be clear and concise. Clearly describe the problem you are addressing, the results to date and any conclusions you can draw from them, so that your abstract can be evaluated by the programme committee. Avoid saying in effect ‘a solution to XYZ problem will be presented’. Please ensure that your abstract is checked for correctness of spelling and grammar in advance of submission.
• Subheadings: Please avoid the use of subheadings in the abstract narrative.
• References: A separate list of references at the end of the abstract is not necessary.
• File name: should be the same as the surname of the presenting author.
• Download a sample abstract document (Microsoft Word), which can be used for formatting purposes.